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ABSTRACT
Objective: Lupus nephritis (LN) is the most common and serious manifestation of systemic lupus erythematosus (SLE) and an important cause of 
morbidity and mortality. Although diagnosis of LN is straight forward in a patient with SLE and proteinuria, and active urine sediment and perhaps 
renal insufficiency, still renal biopsies are required at diagnosis to enable classification of nephritis severity, to provide prognostic information, and to 
guide treatment. Hence, the objective of this study is to determine the frequency of distribution of different classes of LN based on renal biopsy reports 
and to correlate it with various laboratory findings.
Methods: Retrospective study was done in all patients with LN who had at least one representative renal biopsy and evaluated in Nephrology 
Department of SCB Medical College, Cuttack, in 6-month duration. Various laboratory values were recorded and correlated with histopathological 
lupus classifications.
Results: Out of 35 patients enrolled, 33 (94.28%) were females and 2 (5.71%) were males. Mean age was 27.53±12.26 years. Majority of cases belong 
to Class IV followed by Class V. Patients of Class IV LN have a significantly low hemoglobin level. Similarly, serum urea and creatinine are higher in 
Group IV than other groups, and serum creatinine was found to be significant. 24 hrs urinary protein excretion has a significant correlation with the 
classes of LN.
Conclusion: This study suggests some meaningful correlation between laboratory findings and histopathological lupus classification. This study also 
suggests that renal biopsies are still beneficial for better evaluation of renal status and determination of LN classes.
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INTRODUCTION
Systemic lupus erythematosus (SLE) is a chronic disease with 
autoimmune pathogenesis and manifests as a low-grade inflammation 
and may advance to multiorgan fatal damage [1]. The disease prevalence 
differs globally. The annual incidence of SLE in relatively low- to high-
risk groups varies from 6 to 35 cases per 100,000 populations [2,3]. The 
first case of SLE was reported from India in 1965. Reported prevalence 
in northern Indian population ranges from 14 to 60/100,000 [4].
The inflammatory involvement of SLE virtually affects every organ 
including the joints, skin, kidney, brain, serosa, lungs, heart, and 
gastrointestinal tract. Renal involvement of SLE, known as lupus 
nephritis (LN) is a common manifestation and often determines the 
course of the disease. It is also an important cause of morbidity and 
mortality in SLE patients. The incidence of LN in SLE is divergent 
around the world and may be related to different ethnic and genetic 
backgrounds.
Nearly 70-80% of all cases of SLE have some clinical manifestations of 
LN mostly glomerulonephritis [5]. Proteinuria and deterioration of renal 
function were the main indications for renal biopsy. Although diagnosis 
of LN is straight forward in a patient with SLE and proteinuria, and an 
active urine sediment and perhaps renal insufficiency, abnormal renal 
pathology can also occur in the absence of proteinuria or active urine 
sediment [6]. For this reason, renal biopsies are required at diagnosis to 
enable classification of nephritis severity, according to the International 
Society of Nephrology and Renal Pathology Society (ISN-RPS) criteria [7], 
to provide prognostic information, and to guide treatment. Hence, there 
is a need for performing renal biopsies to accurately determine the 
extent of parenchyma damage in LN and to guide treatment.
As there generally exist a good correlation between clinical and 
hematological presentations with renal biopsy in patients with 
LN, so it is of utmost importance to correlate the clinical and 
pathological data in patients with LN for the proper management 
and prognostication. Again this type of correlative study will help 
in better understanding of the pathophysiology of renal involvement 
in this disease.
Numerous studies are available on the clinico-pathological correlation 
in LN patients mainly from developed countries. However, regarding 
this, there are very few publications currently available in a developing 
country in India and probably no such data has been published in 
Odisha (an Eastern state of India) till date.
Therefore, this study was aimed to assess the basic laboratory features 
of LN patients of eastern zone of India with biopsy-proven LN class, 
according to ISN/RPS 2003 classification.
METHODS
A retrospective study was done in all patients with LN who had at 
least one representative renal biopsy and evaluated in Nephrology 
Department of SCB Medical College, Cuttack, in 6-month duration. All 
biopsies with at least 10 glomeruli were reviewed. For the patients 
who had repeated biopsies, samples and laboratory records of the first 
biopsy were used. Each biopsy was classified according to ISN/RPS 
2003 classification system.
Available medical charts of the patients were reviewed. The laboratory 
values were recorded at the time of biopsy for each patient including 
hemoglobin level, white blood cell count, serum total protein, albumin, 
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urea, creatinine, triglycerides, cholesterol, urinalysis, and 24 hrs urine 
protein excretion.
For statistical analysis SPSS computer program was used to determine 
whether there was an association between the laboratory parameters 
and ISN/RPS classification. Values were calculated by student’s t-test 
and analysis of variance. p<0.05 was considered to be statistically 
significant.
RESULTS
Total 35 patients who fulfilled the American Rheumatism Association 
criteria for SLE and underwent renal biopsy were included in the study. 
There was a female preponderance in the studied patients, and only 
two of them were found to be male. Age of the patients ranges from 
6 years to 55 years with a mean age of 27.53±12.26 years.
As per Table 1, maximum number patients fall in the age group of 
21-40 years and only 4 were >40 years of age.
Table 2 shows the distribution of renal biopsies according to ISN/RPS 
2003 classification. It is apparent from the study that majority of cases 
belong to Class IV followed by Class V. No patient was found to be having 
Class I or Class VI.
Distribution of various laboratory tests including hematology, 
biochemistry, and urine analysis among different stages of LN has been 
shown in Table 3. As no patient was found to be having Stage I and VI in 
our study population, so these two groups were not included in this table.
Anemia was observed mainly in Class IV and V. Severe anemia in 
Class IV (8.55±1.2) was statistically significant (p=0.03) when 
compared with other 3 groups. Serum urea and creatinine were studied 
as renal parameters. These two parameters are higher in Group IV than 
other groups, and serum creatinine was found to be significant. Serum 
protein and albumin levels were low in all groups.
Albuminuria was observed in all 4 Classes of LN ranging from traces to 
+4. There was a significant correlation between 24 hrs proteinuria and 
ISN/RPS 2003 classification (p=0.04).
DISCUSSION
LN remains one of the most severe manifestations of SLE and 
associated with substantial morbidity and mortality. The glomerular 
lesions that frequently accompany SLE have been the subject of intense 
investigation by clinicians and pathologists for nearly a half of century.
This study was conducted to find out the frequency of distribution of 
various stages of LN and to correlate different laboratory parameters 
with these stages.
Out of 35 subjects, 33 were females and 2 were male patients 
with a female:male ratio of 16:1. In the present study, the female 
preponderance might be due to small sample size which was only 35 
or due to lack of registry of male patients during last 6 months study 
period. In another study conducted Sanker et al., all the patients were 
found to be females [8]. Various other studies also showed female 
preponderance in the study population [9-11]. Increased frequency of 
SLE among women may be attributed to differences in the metabolism 
of sex hormones and/or gonadotropin-releasing hormones.
Mean age of the study group patients at presentation was found to be 
27.53±12.26 years. Approximately similar results were obtained in 
different parts of India by Shobha et al. [12], where mean age of SLE 
patients was found to be 28.31±10.62 years and Sanker et al. [8] (mean 
age = 28.42). In fact, SLE is a disease of childbearing age. Some authors 
such as Esdaile et al. and Austin et al. have found out that younger age 
(<23 years) is one of the indicators associated with increased rate of 
renal failure and a more rapid progressive course [10,13].
Table 1: Distribution of age in groups (n=35)





Table 2: Frequency of distribution of different classes of lupus 
nephritis according to ISN/RPS 2003 Classification
ISN/RPS classes Frequency (%)
Class I 0 (0)
Class II 3 (8.57)
Class III 6 (17.14)
Class IV 19 (54.28)
Class V 7 (36.84)
Class VI 0 (0)
Table 3: Histopathological classification of laboratory parameter
Laboratory parameters Histopathological classifications (mean±SD) p
Grade II (n=3) Grade III (n=6) Grade IV (n=19) Grade V (n=7)
Hemoglobin (g%) 12.4±2.38 10.58±1.5 8.57±1.2 9.28±1.5 0.03*
TLC 10100±3833 9933.3±2056.5 7755.5±1749.3 8742.8±2349.3 0.10
Serum urea (mg/dl) 20±10.3 59±35.8 91.3±63.5 45±21.8 0.19
Serum creatinine (mg/dl) 0.97±0.47 1.56±1.40 3.13±1.7 1.13±0.55 0.02*
Serum protein (g%) 5.8±1.2 4.83±1.39 5.02±0.78 5.1±0.68 0.78
Serum albumin (g%) 2.7±0.6 2.6±1.09 2.28±0.53 2.37±0.37 0.70
Serum cholesterol (mg/dl) 168±56.5 257.3±62.7 227.7±87.7 216.2±26.1 0.63
Serum triglyceride (mg/dl) 134±29.2 216.16±45.6 224.7±216.2 168.4±33.6 0.7
Urine analysis
Urine albumin
Traces 1 (33.3%) 2 (33.33%) - 1 (14.28%)
+ 2 (66.6%) - 4 (21%) 2 (28.57%)
++ - 2 (33.33%) 7 (36.8%) 3 (42.8%)
+++ - 2 (33.33%) 6 (31.5%) 2 (28.57%)
++++ - - 1 (5.26%) -
24 hrs urinary protein excretion >500 mg/24 hrs
24 hrs urine protein (g/day) 3.28±2.17 2.04±2.31 7.45±4.77 5.64±3.21 0.03*
Urine RBC (+) 1 (33.3%) 5 (83.3%) 10 (52.6%) 4 (57.14%)
Urine WBC (+) 1 (33.3%) 3 (50%) 12 (63.15%) 5 (71.4%)
*p<0.05 - significant
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On observing Table 2, we found none of the subjects were included in 
Class I or VI. Class IV is the most common histological type (54.28%) 
of LN in this zone. This finding is in agreement with some previous 
studies where Group IV was found to be the most common variety 
[5,12,14,15]. Neumann et al. in his study on 150 LN patients found out 
a frequency of 10%, 17%, 53%, and 14% for the Class of II, III, IV, and V, 
respectively [16]. Similarly, Pollak and Pirani conducted their study on 
376 LN patients and observed the overall frequency of Class II, III, IV, 
and V to be 26%, 19%, 37%, and 15%, respectively [17]. On the other 
hand, some researchers such as Apple et al. and Austin et al. found 
Class II and III as the more frequent groups [18,19].
On studying Table 3, anemia was found to be statistically significant in 
Class IV as compared to other classes. Similar findings were observed 
by Shobha et al. [12]. In the study by Austin et al. [19], anemia was 
found to be individually associated with an increased probability of 
renal insufficiency as seen in Class IV. This is probably explained by a 
higher risk for development of anemia secondary to renal failure and 
active hematuria in Class IV. No significant correlation was seen in the 
case of leukocyte count with any class of LN. However, according to 
Esdaile et al., low platelet count was associated with renal insufficiency 
(p=0.04) on multivariant analysis.
Serum urea level was found to be higher, whereas serum creatinine 
was found to be significantly higher in Class IV similar to the study by 
Nezhad and Sepaskhah [5] and Mok et al. [20], who also observed a 
significant correlation of WHO classification and renal function. This 
could be explained by the severity of renal lesion in Class IV. One 
previous study reported that creatinine >2.4 mg/dl is associated with 
poor survival outcome reflecting more severe renal damage [21]. 
According to another study by Yoo et al., more cases of Class IV showed 
progression to severe lesion on subsequent biopsy with an increase in 
serum creatinine level [22].
In our study, the highest protein excretion was found in Class IV. 
Correlation between 24 hrs urine protein excretion and ISN/RPS 2003 
classes was found to be statistically significant and is in agreement with 
the study by Nezhad and Sepaskhah [5], who also found significantly 
elevated 24 hrs urine protein excretion. Our study contradicts the result 
of Mok et al. where no significant correlation was found between 24 hrs 
urinary protein excretion and WHO classes [20]. Our study also showed 
a higher incidence of leukocyturia in Class IV as compared to other 
classes.
We conclude that our study suggests some meaningful correlation 
between laboratory findings and histopathological lupus classification 
on renal biopsy. This study also suggests that renal biopsies are still 
beneficial for better evaluation of renal status and determination of LN 
classes. However, there are some limitations of the present study mainly 
the small size of the study population, and patients were not followed 
up for long to see further clinical, laboratory, and histopathological 
changes of renal status.
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